Interventions for Chronic Liver Disease(Cirrhosis)

Refine your search

Age Cohort
Public Health Function
Level of Care
Published Evidence
Download:

Filtering by:

 
Age Cohort: 25 - 59 years
Health Promotion Disease Prevention Diagnostic Curative Rehabilitative Palliative
Community Level
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight, and diabetes
  • Community engagement [community sensitization on transmission and prevention for hepatitis B and C, including ingestion of native herbs, practices, sharing of sharp objects, tattoos, IV drug use and needle
  • Complete abstinence from alcohol
  • Avoidance of excessive herbal ingestions and over-the-counter painkillers and other hepatotoxic drugs
  • Healthy diet, physical activity, weight management, and tobacco use
  • Safe sex practices
  • Recognition of liver disease signs and symptoms
  • Immediate transfer of suspected cases to a higher-level health care facility
  • Home-based support for complete abstinence from alcohol
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
Primary Care
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight and vaccination
  • Regular clinical check-ups for abdominal masses.
  • Safe blood transfusion
  • Safe injection practice
  • Eliminate unnecessary and unsafe injections
  • Early identification and treatment of schistosomiasis
  • Vaccination: Hepatitis B
  • Screening for hepatitis B and hepatitis C
  • History and
  • Physical examination
  • Viral hepatitis B and C serology
  • Point of care Viral load testing
  • Complete blood count
  • Liver function tests
  • Counselling on avoidance of exacerbating factors
  • Immediate transfer of suspected cases to a higher-level health care facility
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care
Referral Facility: General
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight and vaccination
  • Safe blood transfusion
  • Safe injection practice including eliminating unnecessary and unsafe injections
  • Post-exposure prophylaxis
  • Regular screening for hepatitis B and hepatitis C
  • History
  • Physical examination
  • Viral hepatitis B and C serology
  • PCR (quantitative and qualitative) with genotype
  • Complete blood count
  • Liver function tests
  • Coagulation factors, including PTT, PT, and INR
  • Serum iron, ferritin and TIBC test
  • Alpha 1 antitrypsin test
  • Ultrasonography
  • Transient elastography (TE)
  • Upper GI endoscopy
  • Counselling on avoidance of exacerbating factors
  • Antivirals for viral hepatitis B
  • Pan genotypic direct-acting antivirals (DAA) for viral hepatitis C
  • IV Fluid
  • Blood transfusion
  • Therapeutic paracentesis
  • Diuretics
  • Lactulose
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care*
Referral Facility: Specialist
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight and vaccination
  • Safe blood transfusion
  • Safe injection practice including eliminating unnecessary and unsafe injections
  • Post-exposure prophylaxis
  • Regular screening for hepatitis B and hepatitis C
  • History
  • Physical examination
  • Viral hepatitis B and C serology
  • PCR (quantitative and qualitative) with genotype
  • Complete blood count
  • Liver function tests
  • Coagulation factors, including PTT, PT, and INR
  • Serum iron, ferritin and TIBC test
  • Alpha 1 antitrypsin test
  • Ultrasonography
  • Transient elastography (TE)
  • Upper GI endoscopy
  • Liver biopsy
  • Computed tomography (CT)
  • Electroencephalography (EEG)
  • Counselling on avoidance of exacerbating factors
  • Antivirals for viral hepatitis B
  • Pan genotypic direct-acting antivirals (DAA) for viral hepatitis C
  • IV Fluid
  • Endoscopic band ligation
  • Injection sclerotherapy
  • Blood transfusion
  • Therapeutic paracentesis
  • Diuretics
  • Lactulose
  • Liver transplant
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care
 
Age Cohort: 60+ years
Health Promotion Disease Prevention Diagnostic Curative Rehabilitative Palliative
Community Level
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight, and diabetes
  • Community engagement [community sensitization on transmission and prevention for hepatitis B and C, including ingestion of native herbs, practices, sharing of sharp objects, tattoos, IV drug use and needle
  • Complete abstinence from alcohol
  • Avoidance of excessive herbal ingestions and over-the-counter painkillers and other hepatotoxic drugs
  • Healthy diet, physical activity, weight management, and tobacco use
  • Safe sex practices
  • Recognition of liver disease signs and symptoms
  • Immediate transfer of suspected cases to a higher-level health care facility
  • Home-based support for complete abstinence from alcohol
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
Primary Care
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight
  • Regular clinical check-ups for abdominal masses.
  • Safe blood transfusion
  • Safe injection practice
  • Eliminate unnecessary and unsafe injections
  • Early identification and treatment of schistosomiasis
  • Vaccination: Hepatitis B
  • Screening for hepatitis B and hepatitis C
  • History and
  • Physical examination
  • Viral hepatitis B and C serology
  • Point of care Viral load testing
  • Complete blood count
  • Liver function tests
  • Counselling on avoidance of exacerbating factors
  • Immediate transfer of suspected cases to a higher-level health care facility
  • Counselling and support for complete abstinence from alcohol
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care*
Referral Facility: General
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight
  • Safe blood transfusion
  • Safe injection practice including eliminating unnecessary and unsafe injections
  • Post-exposure prophylaxis
  • Regular screening for hepatitis B and hepatitis C
  • History
  • Physical examination
  • Viral hepatitis B and C serology
  • PCR (quantitative and qualitative) with genotype
  • Complete blood count
  • Liver function tests
  • Coagulation factors, including PTT, PT, and INR
  • Serum iron, ferritin and TIBC test
  • Alpha 1 antitrypsin test
  • Ultrasonography
  • Counselling on avoidance of exacerbating factors
  • Antivirals for viral hepatitis B
  • Pan genotypic direct-acting antivirals (DAA) for viral hepatitis C
  • IV Fluid
  • Blood transfusion
  • Therapeutic paracentesis
  • Diuretics
  • Lactulose
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care*
Referral Facility: Specialist
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight
  • Safe blood transfusion
  • Safe injection practice including eliminating unnecessary and unsafe injections
  • Post-exposure prophylaxis
  • Regular screening for hepatitis B and hepatitis C
  • History
  • Physical examination
  • Viral hepatitis B and C serology
  • PCR (quantitative and qualitative) with genotype
  • Complete blood count
  • Liver function tests
  • Coagulation factors, including PTT, PT, and INR
  • Serum iron, ferritin and TIBC test
  • Alpha 1 antitrypsin test
  • Ultrasonography
  • Counselling on avoidance of exacerbating factors
  • Antivirals for viral hepatitis B
  • Pan genotypic direct-acting antivirals (DAA) for viral hepatitis C
  • IV Fluid
  • Endoscopic band ligation
  • Injection sclerotherapy
  • Blood transfusion
  • Therapeutic paracentesis
  • Diuretics
  • Lactulose
  • Liver transplant
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care*
 
Age Cohort: 12 - 24 years
Health Promotion Disease Prevention Diagnostic Curative Rehabilitative Palliative
Community Level
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight, and diabetes
  • Community engagement [community sensitization on transmission and prevention for hepatitis B and C, including ingestion of native herbs, practices, sharing of sharp objects, tattoos, IV drug use and needle
  • Avoidance of excessive herbal ingestions and over-the-counter painkillers and other hepatotoxic drugs
  • Healthy diet, physical activity, weight management, and alcohol and tobacco use
  • Safe sex practices
  • Recognition of chronic liver disease signs and symptoms
  • Immediate transfer of suspected cases to a higher-level health care facility
  • Home-based support for complete abstinence from alcohol
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
Primary Care
  • Health promotion and education programmes to reduce alcohol consumption, excessive weight
  • Regular clinical check-ups for abdominal masses.
  • Safe blood transfusion
  • Safe injection practice
  • Eliminate unnecessary and unsafe injections
  • Early identification and treatment of schistosomiasis
  • Vaccination: Hepatitis B for individuals, families of carriers
  • Regular screening for hepatitis B and hepatitis C
  • History and
  • Physical examination
  • Viral hepatitis B and C serology
  • Point of care Viral load testing
  • Complete blood count
  • Liver function tests
  • Counselling on avoidance of exacerbating factors
  • Immediate transfer of suspected cases to a higher-level health care facility
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care
Referral Facility: General
  • Safe blood transfusion
  • Safe injection practice including eliminating unnecessary and unsafe injections
  • Post-exposure prophylaxis
  • Regular screening for hepatitis B and hepatitis C
  • History
  • Physical examination
  • Viral hepatitis B and C serology
  • PCR (quantitative and qualitative) with genotype
  • Complete blood count
  • Liver function tests
  • Coagulation factors, including PTT, PT, and INR
  • Serum iron, ferritin and TIBC test
  • Alpha 1 antitrypsin test
  • Ultrasonography
  • Transient elastography (TE)
  • Upper GI endoscopy
  • Liver biopsy
  • Computed tomography (CT) scan
  • Electroencephalography (EEG)
  • Counselling on avoidance of exacerbating factors
  • Antivirals for viral hepatitis B
  • Pan genotypic direct-acting antivirals (DAA) for viral hepatitis C
  • IV Fluid
  • Endoscopic band ligation
  • Injection sclerotherapy
  • Blood transfusion
  • Therapeutic paracentesis
  • Diuretics
  • Lactulose
  • Liver tran
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care
Referral Facility: Specialist
  • Safe blood transfusion
  • Safe injection practice including eliminating unnecessary and unsafe injections
  • Post-exposure prophylaxis
  • Regular screening for hepatitis B and hepatitis C
  • History
  • Physical examination
  • Viral hepatitis B and C serology
  • PCR (quantitative and qualitative) with genotype
  • Complete blood count
  • Liver function tests
  • Coagulation factors, including PTT, PT, and INR
  • Serum iron, ferritin and TIBC test
  • Alpha 1 antitrypsin test
  • Ultrasonography
  • Counselling on avoidance of exacerbating factors
  • Antivirals for viral hepatitis B
  • Pan genotypic direct-acting antivirals (DAA) for viral hepatitis C
  • IV Fluid
  • Blood transfusion
  • Therapeutic paracentesis
  • Diuretics
  • Lactulose
  • Counselling and support for complete abstinence from alcohol
  • Nutritional management
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • End-of-life care